March 24th, 2005
Arstechnica | India , WTO and the pharmaceutical industry
The low cost Indian drug industry has been able to supply the developing world’s need for cheap, good drugs by relying on Indian patent system. The Indian patent system allowed for only process patents not product patents and WTO has forced it to change.
Now the entire developing world may face an acute shortage of cheap generic drugs. Who will be responsible for the millions who will suffer?
